- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of Column Group IV GP, LP
- Signature - Title
- /s/ James Evangelista - James Evangelista, Attorney-in-Fact
- Location
- San Francisco, CA
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Column Group IV GP, LP.
Follow Filing Activity
Follow Column Group IV GP, LP and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Column Group IV GP, LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SRZN | Eikon Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 12% | $131,204,153 | 6,353,712 | Tim Kutzkey | 06 Feb 2026 |
Schedules 13D/G Reported by Column Group IV GP, LP:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.